ERAS PEER ANALYSIS

Erasca Inc — metric-by-metric comparison with peers and the industry median

ERASErasca Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value it Duel

Overall Profile & Returns

· Biotechnology

Position Within Industry

0 = weak quartile, 100 = strong quartile

ERASIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	ERAS	TLX	MSB	CSL	Ind. Median
P/E	—	—	—	29.96	18.06
P/B	14.20	6.38	—	2.24●	3.62
EV/EBITDA	—	120.20	—	10.35●	15.13
P/S	—	3.24	31.30	2.66●	10.65

Financial Health
Metric	ERAS	TLX	MSB	CSL	Ind. Median
Current Ratio	9.52●	1.43	—	2.57	5.90
Debt/Equity	11.7%●	112.3%	—	67.4%	10.9%
NetDebt/EBITDA	0.73●	13.13	—	2.22	1.15

Profitability
Metric	ERAS	TLX	MSB	CSL	Ind. Median
Net Margin	—	-0.9%	-115.3%	9.2%●	-125.7%
ROE	-69.9%	-1.8%	-11.3%	7.7%●	-47.5%
ROA	-59.4%	-0.7%	-8.6%	3.8%●	-35.8%
EBITDA Margin	—	3.0%	-76.6%	32.8%●	-105.8%

Growth + Dividend
Metric	ERAS	TLX	MSB	CSL	Ind. Median
Rev. Growth	-100.0%	56.3%	410.4%●	4.8%	5.1%
NI Growth	—	—	—	-39.4%	12.1%
Div. Yield	—	—	0.0%	2.5%●	0.2%
Payout	—	—	0.0%	103.1%	0.0%

Valuation
Metric	ERAS	CELC	TVTX	LGND	ACLX	DNLI	Ind. Median
P/E	—	—	—	41.36	-28.30●	—	18.06
P/B	14.20	117.75	53.83	6.37	16.10	5.30●	3.62
EV/EBITDA	—	—	139.54	27.11	-30.94●	—	15.13
P/S	—	40,924.92	9.91●	23.14	290.72	—	10.65

Financial Health
Metric	ERAS	CELC	TVTX	LGND	ACLX	DNLI	Ind. Median
Current Ratio	9.52	12.31	3.13	21.28●	4.44	9.28	5.90
Debt/Equity	11.7%	365.4%	331.9%	45.3%	23.9%	4.3%●	10.9%
NetDebt/EBITDA	0.73	-0.29	1.63	-1.47●	1.79	1.92	1.15

Profitability
Metric	ERAS	CELC	TVTX	LGND	ACLX	DNLI	Ind. Median
Net Margin	—	-125,250.6%	-4.0%	55.9%●	-1,027.3%	—	-125.7%
ROE	-69.9%	-275.2%	-32.6%	17.1%●	-53.4%	-49.6%	-47.5%
ROA	-59.4%	-61.4%	-3.9%	12.6%●	-34.8%	-40.0%	-35.8%
EBITDA Margin	—	-112,116.2%	7.2%	81.0%●	-888.3%	—	-105.8%

Growth + Dividend
Metric	ERAS	CELC	TVTX	LGND	ACLX	DNLI	Ind. Median
Rev. Growth	-100.0%	26.9%	96.0%●	51.2%	-79.4%	—	5.1%
NI Growth	—	—	—	—	—	—	12.1%
Div. Yield	—	—	—	—	—	—	0.2%
Payout	—	—	—	—	—	—	0.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on ERAS

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 7, 26. This content is for informational purposes only and is not investment advice.